Arcus Biosciences
RCUS
RCUS
142 hedge funds and large institutions have $2.06B invested in Arcus Biosciences in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 47 increasing their positions, 48 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
2% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 48
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
35% less call options, than puts
Call options by funds: $6.08M | Put options by funds: $9.31M
Holders
142
Holding in Top 10
6
Calls
$6.08M
Puts
$9.31M
Top Buyers
| 1 | +$52.6M | |
| 2 | +$45.5M | |
| 3 | +$38.8M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$16.2M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$15M |
Top Sellers
| 1 | -$62.2M | |
| 2 | -$26.4M | |
| 3 | -$18.4M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$11.1M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$10.4M |